Mesirow Financial Investment Management, Inc. Karyopharm Therapeutics Inc. Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$8.11 - $11.11 $176,084 - $241,220	-21,712 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$9.85 - $17.69 $5,821 - $10,454	-591 Reduced 2.65%	21,712 $228,000
Q4 2020 Jan 14, 2021	BUY	$14.15 - $17.19 $315,587 - $383,388	22,303 New	22,303 $345,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account